In silico optimization of basal insulin infusion rate during exercise: Implication for artificial pancreas

Journal of Diabetes Science and Technology

Volumn 7, Issue 6, 2013, Pages 1461-1469

  Schiavon, Michele ^a   Dalla Man, Chiara ^a   Kudva, Yogish C ^b   Basu, Ananda ^b   Cobelli, Claudio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

Physical activity; Simulation; Type 1 diabetes

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

ARTIFICIAL PANCREAS; BASAL INSULIN INFUSION RATE; CLINICAL ASSESSMENT TOOL; COMPUTER MODEL; CONFERENCE PAPER; CONTROLLED STUDY; EXERCISE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; NORMAL HUMAN; PHYSICAL ACTIVITY; REST;

ALGORITHMS; BLOOD GLUCOSE; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE; HUMANS; HYPOGLYCEMIA; INSULIN; ITALY; MODELS, BIOLOGICAL; PANCREAS, ARTIFICIAL; TIME FACTORS; UNITED STATES;

EID: 84900524266     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700606     Document Type: Article

References (15)

1. Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes. 2011;60(11):2672-82.
2. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50.
3. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
4. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010;375(9716):743-51.
5. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;2(27):27ra27.
6. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle III FJ, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012;61(9):2230-7.
7. Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen J, Wilinska M, Evans M, Hovorka H, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Giordano L, Di Palma F, Soru P, Tofanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L; AP@home Consortium. Day and night closed loop control in adults with type 1 diabetes mellitus: a comparison of two closed loop algorithms driving continuous subcutaneous insulin infusion versus patient self management. Diabetes Care. 2013. Forthcoming.
8. Soru P, De Nicolao G, Tofanin C, Dalla Man C, Cobelli C, Magni L; AP@home Consortium. MPC based artificial pancreas: strategies for individualization and meal compensation. Ann Rev Control. 2012;36(1):118-28.
9. Patek SD, Magni L, Dassau E, Karvetski C, Tofanin C, De Nicolao G, Del Favero S, Breton M, Dalla Man C, Renard E, Zisser H, Doyle III FJ, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng. 2012;59(11):2986-99.
10. Kovatchev BP, Breton M, Dalla Man C, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
11. Dalla Man C, Micheletto F, Dayu L, Breton M, Kovatchev BP, Cobelli C. The UVA/Padova type 1 diabetes simulator: new features. 2013. J Diabetes Sci Technol. Forthcoming.
12. Schiavon M, Hinshaw L, Mallad A, Dalla Man C, Sparacino G, Johnson M, Carter R, Basu R, Kudva Y, Cobelli C, Basu A. Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals. Am J Physiol Endocrinol Metab. 2013;305(4):E557-66.
13. Carter SL, Rennie C, Tarnopolsky MA. Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab. 2001;280(6):E898-907.
14. Kovatchev BP, Straume M, Cox DJ, Farhy LS. Risk analysis of blood glucose data: a quantitative approach to optimizing the control of insulin dependent diabetes. J Theor Med. 2000;3(1):1-10.
15. Magni L, Raimondo DM, Dalla Man C, Breton M, Patek S, Nicolao GD, Cobelli C, Kovatchev BP. Evaluating the eficacy of closed-loop glucose regulation via control-variability grid analysis. J Diabetes Sci Technol. 2008;2(4):630-5.